The publication "Ackermann et al. 2020" shows new insights in the development of human blood stem cells. Ackermann and colleagues used IPSC and organoids to show the formation of blood cells.
The publication „Hahn/Pollmann et al. 2020“ sets the foundation for the first gene therapy of IFNgR1-deficient MSMD. The authors reverse cells from patients with lentiviral vectors. For more information click here.
“Haake et al. 2020“ provides insights into the formation of Mendelian Suscpetibility to Mycobacterial Disease. IPSC from patients are established and point out to be important cells for MSMD. For more information click here.